Vaccine Trials Children
- All
- News
- Videos
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
Data From Trials On 2-18-Year-Olds Very Encouraging: Covaxin Maker
Bharat Biotech today announced that Covaxin, its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III trials.
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Centre's Decision To Vaccinate Children "Unscientific": Senior AIIMS Epidemiologist
A senior epidemiologist at AIIMS who is the principal investigator of Covaxin trials for adults and children at the institute on Sunday termed the Centre's decision to vaccinate children against Covid "unscientific".
-
Bharat Biotech Submits Data On Covid-19 Vaccine Trial In Children
India is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and Managing Director of Bharat Biotech, Krishna Ella said.
-
Pfizer Covid Vaccine Safe For Children Aged 5-11: Clinical Trial Results
Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
No Scientific Body Suggests Kids' Vaccination For School Opening: Centre
Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
-
Recruitment Of Volunteers For Trial Of Covovax Vaccine On Children Begins
Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research In Delhi.
-
Johnson & Johnson Seeks Nod For Vaccine Trials For 12-17 Group In India
Johnson & Johnson has applied for permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group, saying it is critical that "all sections of the population" are vaccinated to ensure achievement of herd immunity status.
-
Panel Recommends Nod To Serum Institute For Covid Jab Trials On Children
An expert panel of the Central Drugs Standard Control Organisation today recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions, sources said
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
Data From Trials On 2-18-Year-Olds Very Encouraging: Covaxin Maker
Bharat Biotech today announced that Covaxin, its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III trials.
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Centre's Decision To Vaccinate Children "Unscientific": Senior AIIMS Epidemiologist
A senior epidemiologist at AIIMS who is the principal investigator of Covaxin trials for adults and children at the institute on Sunday termed the Centre's decision to vaccinate children against Covid "unscientific".
-
Bharat Biotech Submits Data On Covid-19 Vaccine Trial In Children
India is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and Managing Director of Bharat Biotech, Krishna Ella said.
-
Pfizer Covid Vaccine Safe For Children Aged 5-11: Clinical Trial Results
Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
No Scientific Body Suggests Kids' Vaccination For School Opening: Centre
Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
-
Recruitment Of Volunteers For Trial Of Covovax Vaccine On Children Begins
Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research In Delhi.
-
Johnson & Johnson Seeks Nod For Vaccine Trials For 12-17 Group In India
Johnson & Johnson has applied for permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group, saying it is critical that "all sections of the population" are vaccinated to ensure achievement of herd immunity status.
-
Panel Recommends Nod To Serum Institute For Covid Jab Trials On Children
An expert panel of the Central Drugs Standard Control Organisation today recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions, sources said
